Butterfly Network (BFLY) Stock Price, News & Analysis

Company Overview

Butterfly Network is a medical imaging company specializing in point-of-care ultrasound solutions. By combining advanced semiconductor technology with artificial intelligence, the company has developed a compact, handheld ultrasound device designed to provide affordable and accessible imaging for healthcare providers. Its flagship product, Butterfly iQ, integrates seamlessly with mobile devices, allowing clinicians to perform diagnostic scans and capture high-resolution images without the bulk and cost associated with traditional ultrasound systems.

Butterfly iQ operates on a software-driven platform that supports cloud storage, AI-powered image analysis, and remote collaboration. This connectivity enables real-time telemedicine consultations, decision support tools, and streamlined workflow management. Subscription-based services provide customers with regular software updates, educational resources, and technical support, helping hospitals, clinics, and individual practitioners optimize imaging protocols and improve patient care.

Founded in 2011 by entrepreneur and scientist Dr. Jonathan Rothberg, Butterfly Network is headquartered in Guilford, Connecticut. The company went public in 2021 and has since expanded its leadership team to include CEO Dr. Todd Fruchterman, whose background in medical device innovation and digital health guides the company’s strategic growth. Butterfly Network’s board and executive team combine experience in engineering, clinical practice, and finance to drive product development and global expansion.

Butterfly Network serves a diverse range of geographies, including North America, Europe, Asia-Pacific, and Latin America. Its technology is used by large hospital systems, community clinics, academic institutions, and veterinary practices, reflecting broad applicability across human and animal health. Through partnerships with healthcare organizations and research institutions, Butterfly Network aims to advance point-of-care diagnostics, reduce barriers to medical imaging, and improve outcomes for patients worldwide.

Key Stats

• Today's Range: $1.92 to $2.02
• 50-Day Range: $1.94 to $2.63
• 52-Week Range: $0.90 to $4.98
• Volume: 4.65 million shs
• Average Volume: 3.21 million shs
• Market Capitalization: $493.34 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.50
• Consensus Rating: Buy

Butterfly Network Stock Analysis - MarketRank™

Butterfly Network scored higher than 49% of companies evaluated by MarketBeat, and ranked 537th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Butterfly Network has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Butterfly Network has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Butterfly Network are expected to grow in the coming year, from ($0.35) to ($0.33) per share.

Price to Book Value per Share Ratio

Butterfly Network has a P/B Ratio of 2.53. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.93% of the float of Butterfly Network has been sold short.

Short Interest Ratio / Days to Cover

Butterfly Network has a short interest ratio ("days to cover") of 5.5.

Change versus previous month

Short interest in Butterfly Network has recently increased by 11.32%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Butterfly Network does not currently pay a dividend.

Dividend Growth

Butterfly Network does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

8.93% of the float of Butterfly Network has been sold short.

Short Interest Ratio / Days to Cover

Butterfly Network has a short interest ratio ("days to cover") of 5.5.

Change versus previous month

Short interest in Butterfly Network has recently increased by 11.32%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 0.34

News Sentiment

Butterfly Network has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Butterfly Network this week, compared to 4 articles on an average week.

Search Interest

16 people have searched for BFLY on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.

MarketBeat Follows

Only 3 people have added Butterfly Network to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Butterfly Network insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $925,328.00 in company stock.

Percentage Held by Insiders

25.18% of the stock of Butterfly Network is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 37.85% of the stock of Butterfly Network is held by institutions.

BFLY Stock Analysis - Frequently Asked Questions

How have BFLY shares performed this year?

Butterfly Network's stock was trading at $3.12 on January 1st, 2025. Since then, BFLY stock has decreased by 36.1% and is now trading at $1.9950.

How were Butterfly Network's earnings last quarter?

Butterfly Network, Inc. (NYSE:BFLY) announced its earnings results on Friday, May, 2nd. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.09) by $0.03. The company earned $21.23 million during the quarter, compared to analysts' expectations of $21.16 million. Butterfly Network had a negative net margin of 75.56% and a negative trailing twelve-month return on equity of 29.97%.
Read the conference call transcript.

How do I buy shares of Butterfly Network?

Shares of BFLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Butterfly Network own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Butterfly Network investors own include Scilex (SCLX), Enovix (ENVX), Rigetti Computing (RGTI), AU Optronics (AUOTY), Ginkgo Bioworks (DNA), American Water Works (AWK) and Waste Connections (WCN).

Company Calendar

• Last Earnings: 5/02/2025
• Today: 7/06/2025
• Next Earnings (Estimated): 8/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:BFLY
• CIK: 1804176
• Web: www.butterflynetwork.com
• Phone: 781-557-4800
• Fax: N/A
• Employees: 460
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $3.50
• High Stock Price Target: $4.00
• Low Stock Price Target: $3.00
• Potential Upside/Downside: +75.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.29)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$72.49 million
• Net Margins: -75.56%
• Pretax Margin: -75.59%
• Return on Equity: -29.97%
• Return on Assets: -21.13%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.06
• Quick Ratio: 4.43

Sales & Book Value

• Annual Sales: $82.06 million
• Price / Sales: 6.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.79 per share
• Price / Book: 2.53

Miscellaneous

• Outstanding Shares: 247,290,000
• Free Float: 185,022,000
• Market Cap: $493.34 million
• Optionable: Optionable
• Beta: 2.46